Active Litigation
Ethylene Oxide Lawsuit Facts
TorHoerman Law is actively accepting claims for the Ethylene Oxide Lawsuit.
Active Litigation
TorHoerman Law is actively accepting claims for the Ethylene Oxide Lawsuit.
The Sterigenics Willowbrook cancer map depicts the areas at greatest risk of harmful exposure from ethylene oxide (EtO) emissions released by the former medical sterilization facility in Willowbrook, Illinois.
The map outlines one-, two-and-a-half-, and five-mile radiuses around the site, identifying communities that may have faced elevated risks of cancer and other serious health conditions linked to toxic emissions.
By illustrating these exposure zones, residents and former workers can better understand the long-term health impacts associated with ethylene oxide in the surrounding environment.

The Sterigenics Willowbrook cancer map highlights the areas at risk of elevated cancer risk from ethylene oxide (EtO) emissions originating at the shuttered Willowbrook sterilization plant.
This chemical, a toxic gas widely used to sterilize medical equipment and medical devices, was classified by the Environmental Protection Agency (EPA) as a human carcinogen due to clear evidence that long-term exposure raises the chance of cancer and other serious health effects.
Between the plant’s operations and its closure in 2019, hundreds of ethylene oxide exposure lawsuit claims linked to the Sterigenics Willowbrook facility were filed and settled.
The map above outlines one-, two-and-a-half-, and five-mile radiuses around the Willowbrook plant, depicting zones where released ethylene oxide may have caused elevated lifetime cancer risks.
Residents and workers within the innermost one-mile radius faced the greatest exposure, given the likelihood of higher concentrations of toxic emissions.
Those within the 2.5-mile band still encountered significant risk, while the five-mile ring illustrates how broader areas (schools, neighborhoods and workplaces) may have been affected by plume dispersion.
Scientific modeling and ambient monitoring show that weather patterns, terrain and emission pathway variations can extend exposure well beyond the immediate vicinity, making some downwind communities disproportionately impacted.
For individuals already diagnosed with health issues like breast cancer, leukemia or lymphoma, proximity to the closed facility has become a pivotal part of their medical and legal narrative.
This map is designed to help visualize the exposure footprints identified by regulators, expert studies and historical operations of the Willowbrook plant, providing a clearer picture of where toxic chemical exposure may have taken place.
If you or a loved one lived, worked or attended school near the Sterigenics Willowbrook facility and later developed cancer or other serious health problems linked to exposure to ethylene oxide, you may be eligible to pursue legal action and seek compensation for the harm caused.
Contact TorHoerman Law today for a free consultation.
You can also use the chat feature on this page to get in touch with our team of ethylene oxide exposure lawyers.
Understanding the risk profile for communities near the Willowbrook plant requires looking at both distance (how close someone lived, worked, or attended school) and duration (how long or how often exposure to the sterilizing agent occurred).
In its risk assessment, the Environmental Protection Agency (EPA) estimated lifetime cancer risks for individuals exposed to ambient air from the facility.
The agency assumed a scenario of continuous inhalation exposure for 70 years in residential settings to approximate worst-case cumulative effects.
Because the facility handled large volumes of ethylene oxide (EtO), a chemically reactive gas used to sterilize medical devices and now classified as a human carcinogen, communities and workers exposed nearby face significant health risks.
Many studies have found that long-term inhalation of EtO is linked to cancers of the white blood cells, such as non-Hodgkin lymphoma and lymphocytic leukemia, as well as breast cancer and other lymphohematopoietic cancers.
Ethylene oxide exposure risks are not uniformly distributed.
Factors like prevailing wind direction, emission points (e.g., chamber vents, back-vents, aeration rooms), and topography can concentrate toxic air in certain downwind neighbourhoods.
In addition to cancer risks, non-cancer health effects such as peripheral neuropathy, memory loss, impaired coordination, and respiratory irritation have been observed or flagged in health agency reviews, especially among residents and workers with higher exposures.

Below are specific health risks and effects that people living within approximate radiuses of 1 mile, 2.5 miles and 5 miles around the Willowbrook facility may face, and how these effects tend to develop or manifest:
Residents within the first one-mile radius of the sterilization plant typically faced the highest average exposure levels and therefore the greatest likelihood of elevated health risks.
From 1 to 2.5 miles, risk decays but remains elevated depending on direction and meteorological conditions; by 5 miles, risk is reduced but not negligible, especially in areas under consistent downwind conditions and weaker emission controls.
This detailed risk profile shows how toxic substances from commercial sterilization facilities like the Sterigenics Willowbrook plant can cause real and measurable harm in ambient air for neighbouring communities and exposed workers.
Environmental factors play a critical role in determining how far released ethylene oxide (EtO) travels and where it accumulates, turning a chemical leak into a potential public health hazard for nearby communities.
The Environmental Protection Agency has classified ethylene oxide as a cancer-causing chemical, meaning that even low concentrations of this colorless gas can contribute to elevated cancer risk and other serious health effects.
At the Sterigenics Willowbrook plant, for example, persistent hazardous emissions from sterilizing equipment and associated aeration chambers created conditions that public health advocates say amplified exposure in downwind neighborhoods.
Terrain, prevailing wind patterns, atmospheric stability (such as inversion layers), and proximity to emission points interact in unpredictable ways, so two homes at the same distance from the facility may face vastly different risks.
Some areas ended up with significantly higher ambient air concentrations of EtO than model averages, particularly when the sterilizing agent was vented without enhanced emission controls.
Beyond cancer, subsidiary risks such as peripheral neuropathy, respiratory irritation, and reproductive toxicity arise more frequently in zones where emission mitigation was weak or delayed.

Federal and state agencies now recognize that communities and workers exposed within a 1- to 5-mile radius of commercial sterilization facilities are among the most vulnerable to both cancer-linked and non-cancer health conditions.
The effectiveness of emission control upgrades (testing filters, installing scrubbers, monitoring fence-lines) can dramatically alter the exposure profile, yet gaps in implementation mean many affected neighborhoods still face higher levels of risk.
The now-closed Willowbrook sterilization plant has become the focus of significant litigation after communities raised concerns over prolonged exposure to the colorless gas Ethylene Oxide (EtO) and documented adverse health effects.
Plaintiffs alleged that emissions from the facility led to elevated cancer rates, including individuals who developed breast cancer, chronic lymphocytic leukemia, and other lymphohematopoietic cancers after years of living nearby.
In one landmark verdict, a Cook County jury awarded $363 million to a single plaintiff who had a cancer diagnosis tied to her proximity to the plant.
In January 2023 Sterigenics agreed to a settlement of approximately $408 million to resolve more than 870 claims stemming from the Willowbrook facility.
The lawsuits underscore the community health impacts of EtO emissions and reflect a wider trend of residents seeking financial compensation from commercial sterilization facilities that used hazardous substances for medical device sterilization.
Even though the plant is no longer operating, legal counsel continues to explore remaining and future claims tied to its historical emissions and associated safety risk exposures.

Key developments surrounding the Sterigenics Willowbrook Facility and associated lawsuits:
At TorHoerman Law, we are actively reviewing potential claims connected to the Sterigenics Willowbrook facility, including individuals diagnosed with cancer or other serious health conditions after exposure to EtO emissions, even though the facility has been closed since 2019.
Our legal team continues to monitor developments and gather evidence that may qualify impacted residents or former workers to seek compensation.
We understand the challenges of proof in exposure cases and are prepared to assist claimants with documenting their exposure, establishing proof of harm, and navigating litigation timelines.
If you believe you were exposed and later developed health conditions tied to the Willowbrook facility, it is essential you speak with experienced counsel promptly.
Building a strong ethylene oxide lawsuit requires clear and verifiable evidence showing a connection between exposure and illness.
Individuals pursuing claims related to the Sterigenics plant should collect documentation that demonstrates proximity to emissions, medical proof of harm, and records linking the timeline of exposure to a serious illness.
Lawyers often rely on a combination of environmental testing data, witness accounts, and health documentation to establish liability in toxic exposure cases.

The following types of evidence can help strengthen an EtO claim:
In lawsuits involving the Sterigenics sterilization plant, plaintiffs in cancer cases linked to the facility have secured substantial compensation for harms caused by toxic emissions.
A landmark case in 2022 resulted in a $363 million verdict for a woman who developed breast cancer after long-term exposure, which included $38 million in compensatory damages and $325 million in punitive damages.
In January 2023, the company settled roughly 870 claims for $408 million, reflecting the serious exposure and community health impacts tied to the facility’s operations.
These outcomes demonstrate how courts recognize the real burden of medical bills, lost wages, emotional suffering and other harms when surrounding communities and workers were exposed to ethylene oxide.
Each claim is unique, and compensation varies based on diagnosis severity, proximity and duration of exposure, and other factors.

Potential damages in a Sterigenics lawsuit claim:
If you or a loved one developed cancer or another serious illness after living, working, or attending school near a Sterigenics facility, you may be eligible to seek compensation for this harm.
The Sterigenics Willowbrook facility may have closed in 2019, but its impact on the surrounding community continues to raise serious health and environmental concerns.
Hundreds of residents have filed claims alleging that long-term exposure to ethylene oxide emissions from the plant caused them to develop breast cancer, lymphocytic leukemia, and other life-threatening illnesses.
At TorHoerman Law, we continue to investigate the legacy of contamination left by this facility and pursue justice for families affected by years of toxic exposure.
Our legal team reviews medical and environmental evidence, partners with health experts, and builds comprehensive claims for those harmed by Sterigenics’ operations.
TorHoerman Law remains committed to holding corporations accountable when their medical sterilization practices and hazardous emissions endanger public health.
Every case we handle represents a step toward transparency, accountability, and safer communities across Illinois and beyond.

If you or a loved one lived or worked near the Sterigenics Willowbrook plant and later developed cancer or other serious health conditions, you may be eligible to file a lawsuit and seek compensation.
Contact TorHoerman Law for a free case evaluation or use the chat feature on this page to find out if you qualify for an Ethylene Oxide lawsuit today.
When compared to other airborne substances, the distance that Ethylene Oxide (EtO) can travel from a sterilization or chemical facility is not fixed, as its spread depends on multiple factors.
According to the U.S. Environmental Protection Agency (EPA), how far EtO reaches in a community depends on the amount emitted, the point of release (e.g., stack height, fugitive vents), local wind patterns, topography, and how long someone is exposed.
Real-world studies document that elevated levels of EtO can be found even several miles from emission sources.
For example, one National Institutes of Health study found increased breast cancer risk among residents living within 6 miles of EtO-emitting facilities.
In another monitoring case in Louisiana’s industrial corridor, mobile lab measurements detected EtO concentrations that were potentially harmful up to 6 miles (~10 km) downwind of large chemical facilities.
Despite these findings, the EPA emphasizes there is no specific “safe distance” guaranteed for all communities because dispersion, emission controls, and local geography vary widely.
Communities living or working within a 1 to 5 mile radius of a facility that emits EtO may face elevated risks, especially if the facility has a history of high emissions, weak controls or is situated in a valley or downwind area.
Continuous exposure over time in such zones can lead to greater lifetime risk of cancer and other serious health conditions.
Communities can face greater risk of exposure to ethylene oxide (EtO) based on multiple interacting factors beyond simple proximity to a sterilization facility.
The Environmental Protection Agency (EPA) points out that how much EtO is in the air, how far away someone is from the emission source, and how long they are exposed play major roles in their risk level.
Vulnerable populations, such as children, the elderly, and those with pre-existing respiratory conditions, are more susceptible to adverse health effects when exposed.
Risk factors that increase community exposure to Ethylene Oxide include:
Because of these factors, some communities near sterilization or chemical plants have seen elevated cancer rates and non-cancer health conditions tied to EtO exposure, while other nearby areas with similar distance may not show as high risks due to better controls or favorable dispersion.
When compared to other chemicals, exposure to Ethylene Oxide (EtO) is well-linked to a distinct set of cancers, meaning these are types for which sufficient or suggestive evidence supports a connection.
According to the Environmental Protection Agency (EPA), long-term inhalation exposure to EtO increases the risk of cancers of the white blood cells, such as Non‑Hodgkin lymphoma, multiple myeloma and Lymphocytic leukemia.
The National Cancer Institute (NCI) also notes that breast cancer in women has been associated with EtO exposure in occupational and community settings.
Some research points toward links with stomach cancer, pancreatic cancer and brain cancer, although the evidence for these is less consistent and still emerging.
Major cancers linked to Ethylene Oxide exposure include:
Because risk depends on dose, duration and timing of exposure (as well as other factors like genetics or other chemical exposures) being near a facility or workplace where EtO is released does not guarantee cancer, but it elevates risk in exposed workers and communities.
Sterilization facilities continue to rely on Ethylene Oxide (EtO) because it remains the only method that consistently meets the complex demands of modern medical device sterilization, especially for items that must remain intact after treatment.
According to the Centers for Disease Control and Prevention (CDC), EtO is used for devices that cannot withstand heat, moisture or radiation without damage, making it indispensable for many plastics, lumens, and electronics.
The chemical’s ability to penetrate packaging, plastics, and complex device geometries gives it a level of material compatibility unmatched by alternative sterilants.
While other methods (such as vaporized hydrogen peroxide or radiation) are available, they often have limitations in penetration, material compatibility or cost effectiveness.
For example, devices with long narrow lumens, multi-layer packaging or electronics embedded in plastic often cannot be reliably sterilized without using EtO.
Additionally, regulatory and supply-chain pressures make it difficult to phase out EtO rapidly: the Food and Drug Administration (FDA) has warned that no other method is yet scalable enough to replace EtO across the entire spectrum of sterile medical devices.
Lastly, economic and process considerations also favor EtO for high-volume, low-temperature sterilization runs, which many sterilizing agents cannot match without compromising device integrity or throughput.

Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.
TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.
TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.
You can learn more about this topic by visiting any of our Ethylene Oxide Lawsuit pages listed below:
A serious injury can change your life.

TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.
Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!

In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.

In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.

In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.

In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.

In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
A serious injury can change your life.